Amgen to buy Onyx for $5 per share more than initial bid
August 25, 2013 at 21:11 PM EDT
Amgen Inc. will buy Onyx Pharmaceuticals Inc. for $10.4 billion cash, or the equivalent of $125 per share — picking up $5 per share from Amgen’s initial bid...
